Several recent studies indicate that IL-6 is a novel Notch target in breast cancer cells and enhanced Notch signaling upregulates the IL-6 expression, leading to activation of autocrine and paracrine Jak/STAT signaling. Here, IL6 is linked to breast carcinoma.